FDX
40
4
V
66
6
MCD
50
-2
FTI
76
3
IVZ
48
2
BA
49
-3
ORCL
67
2
MOS
46
4
GWW
71
4
SYK
68
4
AMZN
55
-3
FLR
55
6
FMC
33
2
ORLY
60
7
D
45
5
PPL
59
5
MRO
40
-15
NTAP
66
2
VTR
54
5
EMN
56
7
FDX
40
4
V
66
6
MCD
50
-2
FTI
76
3
IVZ
48
2
BA
49
-3
ORCL
67
2
MOS
46
4
GWW
71
4
SYK
68
4
AMZN
55
-3
FLR
55
6
FMC
33
2
ORLY
60
7
D
45
5
PPL
59
5
MRO
40
-15
NTAP
66
2
VTR
54
5
EMN
56
7
Financhill
Back

Protagonist Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
33

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
33
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 41.01 Sell
Chaikin Money Flow: -281616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.23 - 47.93) Sell
Bollinger Bands (100): (38.1 - 46.24) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.17 Buy
20-day SMA: 44.7 Sell
50-day SMA: 45.23 Sell
200-day SMA: 35.68 Buy
8-day EMA: 41.66 Sell
20-day EMA: 43.5 Sell
50-day EMA: 43.92 Sell
200-day EMA: 36.78 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):